- Taiwanese male subjects between 50 and 80 years of age who had: a primary diagnosis
of BPH, defined as having an enlarged prostate (confirmed by digital rectal
examination [DRE] and/or B-mode ultrasound); an IPSS score of ≥12; and a Qmax in the
range of 5 to 15 mL/sec in a total voided volume of ≥150 mL, were eligible for the
- Previous prostate surgery, presence of a prostate stent or microwave thermotherapy
and/or balloon dilatation within the previous 6 months
- Concomitant therapy or previous therapy within 14 days with agents known to affect
bladder or urethral function.